BioLargo, Inc. – OTC:BLGO
BioLargo stock price today
BioLargo stock price monthly change
BioLargo stock price quarterly change
BioLargo stock price yearly change
BioLargo key metrics
Market Cap | 63.34M |
Enterprise value | 54.89M |
P/E | -10.1 |
EV/Sales | 12.00 |
EV/EBITDA | -9.86 |
Price/Sales | 11.95 |
Price/Book | 11.01 |
PEG ratio | -0.36 |
EPS | -0.01 |
Revenue | 13.24M |
EBITDA | -4.28M |
Income | -3.66M |
Revenue Q/Q | 27.20% |
Revenue Y/Y | 52.92% |
Profit margin | -126.33% |
Oper. margin | -117.94% |
Gross margin | 48.47% |
EBIT margin | -117.94% |
EBITDA margin | -32.37% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBioLargo stock price history
BioLargo stock forecast
BioLargo financial statements
| Jun 2023 | 1.44M | -1.32M | -91.84% |
|---|---|---|---|
| Sep 2023 | 2.67M | -1.2M | -44.91% |
| Dec 2023 | 4.37M | -729K | -16.68% |
| Mar 2024 | 4.76M | -410K | -8.61% |
| Mar 2024 | 4.76M | -410K | -8.61% |
|---|---|---|---|
| Sep 2025 | 6.7M | 0 | |
| Oct 2025 | 6.07M | 0 | |
| Dec 2025 | 6.42M | 0 |
Analysts Price target
Financials & Ratios estimates
| 2022-08-15 | -0.00497 | -0.00471 |
|---|---|---|
| 2022-11-14 | -0.00178 | -0.00186 |
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | |
| 2023 | 0.5% |
| Jun 2023 | 6680000 | 2.55M | 38.28% |
|---|---|---|---|
| Sep 2023 | 6545000 | 2.72M | 41.68% |
| Dec 2023 | 8205000 | 4.00M | 48.79% |
| Mar 2024 | 9821000 | 4.67M | 47.58% |
| Jun 2023 | -1.48M | -79K | 1.88M |
|---|---|---|---|
| Sep 2023 | -836K | -205K | 507K |
| Dec 2023 | -2K | -146K | 761K |
| Mar 2024 | 481K | -863K | 1.08M |
BioLargo alternative data
| Aug 2023 | 33 |
|---|---|
| Sep 2023 | 32 |
| Oct 2023 | 32 |
| Nov 2023 | 32 |
| Dec 2023 | 32 |
| Jan 2024 | 32 |
| Feb 2024 | 32 |
| Mar 2024 | 32 |
| Apr 2024 | 32 |
| May 2024 | 31 |
| Jun 2024 | 31 |
| Jul 2024 | 31 |
BioLargo other data
| Period | Buy | Sel |
|---|---|---|
| Sep 2017 | 61792 | 0 |
| Mar 2018 | 443969 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | STROMMEN JACK B. director | Warrant to Purchase Common Stock | 333,333 | $0.3 | $100,000 | ||
Purchase | STROMMEN JACK B. director | Common Stock | 110,636 | $0.27 | $29,650 | ||
Purchase | STROMMEN JACK B. director | Common Stock | 61,792 | $0.49 | $30,278 | ||
Option | CALVERT DENNIS P director, officer.. | Common Stock | 2,501,937 | $0.18 | $450,349 | ||
Purchase | COX GARY ADRIAN director | OPTION TO PURCHASE COMMON STOCK | 31,915 | $0.47 | $15,000 | ||
Purchase | ROBERTS KENT CHARLES II director | Common Stock | 142,858 | $0.35 | $50,000 | ||
Purchase | IOWC TECHNOLOGIES, INC. 10 percent owner | Common Stock | 22,139,012 | N/A | N/A | ||
Sale | COX GARY ADRIAN director | Common Stock | 200,000 | $0.04 | $7,000 | ||
Sale | HARRISON STEVEN V director | Common Stock | 55,000 | $0.07 | $3,850 | ||
Sale | HARRISON STEVEN V director | Common stock | 55,000 | $0.07 | $3,850 |
| Quarter | Transcript |
|---|---|
| Q4 2023 2 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 20 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 18 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 18 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of BioLargo stock today?
One share of BioLargo stock can currently be purchased for approximately $0.19.
-
When is BioLargo's next earnings date?
Unfortunately, BioLargo's (BLGO) next earnings date is currently unknown.
-
Does BioLargo pay dividends?
No, BioLargo does not pay dividends.
-
How much money does BioLargo make?
BioLargo has a market capitalization of 63.34M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 107.85% to 12.23M US dollars. BioLargo made a loss 3.5M US dollars in net income (profit) last year or -$0 on an earnings per share basis.
-
What is BioLargo's stock symbol?
BioLargo, Inc. is traded on the OTC under the ticker symbol "BLGO".
-
What is BioLargo's primary industry?
Company operates in the Basic Materials sector and Chemicals industry.
-
How do i buy shares of BioLargo?
Shares of BioLargo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BioLargo's key executives?
BioLargo's management team includes the following people:
- Mr. Dennis P. Calvert Chairman, Pres & Chief Executive Officer(age: 62, pay: $320,300)
- Mr. Kenneth Reay Code Chief Science Officer & Director(age: 78, pay: $301,200)
- Mr. Joseph L. Provenzano Executive Vice President of Operations, Corporation Sec. & Director(age: 56, pay: $186,560)
-
How many employees does BioLargo have?
As Jul 2024, BioLargo employs 31 workers, which is 3% less then previous quarter.
-
When BioLargo went public?
BioLargo, Inc. is publicly traded company for more then 23 years since IPO on 19 Dec 2001.
-
What is BioLargo's official website?
The official website for BioLargo is biolargo.com.
-
Where are BioLargo's headquarters?
BioLargo is headquartered at 14921 Chestnut Street, Westminster, CA.
-
How can i contact BioLargo?
BioLargo's mailing address is 14921 Chestnut Street, Westminster, CA and company can be reached via phone at +888 4002863.
BioLargo company profile:
BioLargo, Inc.
biolargo.comOTC
31
Chemicals
Basic Materials
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. Its flagship products include CupriDyne Clean, a deodorizer is used by industry to control odors at landfills, waste transfer stations, wastewater processing facilities, and others, as well as is used by consumers to control odors on pets and for household odors; Aqueous Electrostatic Concentrator, which removes PFAS from water; and Advanced Oxidation water treatment system that provides disinfection against bacteria, viruses, and protozoa while eliminating hard-to-treat organic contaminants. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
Westminster, CA 92683
CIK: 0000880242
ISIN: US09065A1007
CUSIP: 09065A100
